David T. Baird

Regulation of human endometrial function: mechanisms relevant to uterine bleeding (2006)

Critchley, Hilary OD, Kelly, Rodney W, Baird, David T, Brenner, Robert M

Abstract This review focuses on the complex events that occur in the endometrium after progesterone is withdrawn (or blocked) and menstrual bleeding ensues. A detailed understanding of these local...

Mifepristone-induced amenorrhoea is associated with an increase in microvessel density and glucocorticoid receptor and a decrease in stromal vascular endothelial growth factor (2006)

Narvekar, Nitish, Critchley, Hilary O.D., Cheng, Linan, Baird, David T.

BACKGROUND: We have previously shown that the progesterone antagonist mifepristone is a contraceptive when given in a dose of 2 or 5 mg per day. The majority of women experience amenorrhoea rather...

Mifepristone-induced amenorrhoea is associated with an increase in microvessel density and glucocorticoid receptor and a decrease in stromal vascular endothelial growth factor (2006)

Narvekar, Nitish, Critchley, Hilary O.D., Cheng, Linan, Baird, David T.

BACKGROUND: We have previously shown that the progesterone antagonist mifepristone is a contraceptive when given in a dose of 2 or 5 mg per day. The majority of women experience amenorrhoea rather...

Mifepristone-induced amenorrhoea is associated with an increase in microvessel density and glucocorticoid receptor and a decrease in stromal vascular endothelial growth factor (2006)

Narvekar, Nitish, Critchley, Hilary O.D., Cheng, Linan, Baird, David T.

BACKGROUND: We have previously shown that the progesterone antagonist mifepristone is a contraceptive when given in a dose of 2 or 5 mg per day. The majority of women experience amenorrhoea rather...

Clinical evidence for an LH 'ceiling' effect induced by administration of recombinant human LH during the late follicular phase of stimulated cycles in World Health Organization type I and type II anovulation (2003)

Loumaye, Ernest, Engrand, Patrick, Shoham, Zeev, Hillier, Stephen G., Baird, David T.

BACKGROUND: The objective of these studies was to test the hypothesis that over‐dosing with recombinant human LH (rLH) during the late follicular phase would suppress the development of...

Is there a place for different isoforms of FSH in clinical medicine?: IV. The clinician's point of view (2001)

Baird, David T.

Follicle stimulating hormone (FSH) plays an important role in gametogenesis in both men and women. In men it is required for the establishment and probably maintenance of spermatogenesis. In women it...

Double-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation (2001)

Bartley, Julia, Brown, Audrey, Elton, Rob, Baird, David T.

BACKGROUND: Gemeprost and misoprostol are two of the most widely used prostaglandins in combination with mifepristone for medical abortion in early pregnancy. However, the efficacy and side-effects...

Feasibility of administering mifepristone as a once a month contraceptive pill (2001)

Hapangama, Dharani K., Brown, Audrey, Glasier, Anna F., Baird, David T.

Many women find the idea of a once-a-month contraceptive pill an attractive concept. Mifepristone has been shown to be effective as a contraceptive if administered in the early luteal phase. We...

Dose-finding study of oral desogestrel with testosterone pellets for suppression of the pituitary-testicular axis in normal men (2000)

Martin, Cameron W., Riley, Simon C., Everington, Dawn, Groome, Nigel P., Riemersma, Rudolph A., Baird, David T., ...

Prototype hormonal male contraceptive regimens generally achieve only incomplete suppression to azoospermia with potentially adverse metabolic effects. We have carried out a short-term dose-finding...

Overview of advances in contraception (2000)

Baird, David T

For most of man′s existence, natural checks on fertility ensured that the numbers of the population more or less matched the resources available. It is only in the last few generations that man has...

Preliminary experience of the use of a gonadotrophin-releasing hormone antagonist in ovulation induction/in-vitro fertilization prior to cancer treatment: Case Report (1999)

Anderson, Richard A., Kinniburgh, David, Baird, David T.

Therapeutic regimens for the treatment of malignant disease may compromise future fertility. One approach to circumvent this is the cryopreservation of embryos created before treatment for the...

The effects of post-ovulatory administration of onapristone on the development of a secretory endometrium (1996)

Cameron, Sharon T., Critchley, Hilary O.D., Buckley, C.Hilary, Chard, Tim, Kelly, Rodney W., Baird, David T.

The purpose of this study was to assess the ability of the anti-progestin onapristone administered in the immediate post-ovulatory period to disrupt endometrial differentiation as a potential method...

Uterus and endometrium: Effects of daily low dose mifepristone on endometrial maturation and proliferation (1996)

Cameron, Sharon T., Critchley, Hilary O.D., Thong, K. Joo, Buckley, C. Hilary, Williams, Alistair R., Baird, David T.

Following an ovulatory control cycle, six women took 2 mg of mifepristone daily for 30 days. Endometrial biopsies were collected in the control cycle between 7 and 11 days after the plasma...

Andrology: Failure of oestrogen induced luteinizing hormone surge in women treated with mifepristone (RU 486) every day for 30 days (1995)

Baird, David T., Thong, K.J., Hall, C., Cameron, S.T.

It has been demonstrated previously that administration of the antiprogestin mifepristone (RU 486; 1–5 mg daily) inhibits or delays both the pre-ovulatory luteinizing hormone (LH) surge and...

Endocrinology: Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion (1995)

Baird, David T., Sukcharoen, Nares, Thong, K.Joo

Mifepristone (600 mg) in combination with a prostaglandin has been demonstrated to be a safe, acceptable alternative to vacuum aspiration for induction of abortion in the first 9 weeks of pregnancy....

Ethics and Society: Donated ovarian tissue in embryo research and assisted conception--the view of women of reproductive age (1995)

Lyall, Helen, Murray, Elizabeth, Glasier, Anna, Baird, David T.

In response to widespread interest by the media, the Human Fertilisation and Embryology Authority (HFEA) recently produced a document entitled ‘Donated Ovarian Tissue in Embryology Research and...

The effects of mifepristone (RU486) on prostaglandin dehydrogenase in decidual and chorionic tissue in early pregnancy (1993)

Cheng, Linan, Kelly, Rodney W., Thong, K.Joo, Hume, Robert, Baird, David T.

Prostaglandin dehydrogenase is the main inactivating enzyme for prostaglandins and therefore controls local levels of prostaglandins. Since there is some evidence that the expression of this enzyme...

Pregnancy: The effect of dose of mifepristone and gestation on the efficacy of medical abortion with mifepristone and misoprostol (1993)

McKinley, Carolyn, Thong, K. Joo, Baird, David T.

Although it has been demonstrated that a combination of mifepristone and a prostaglandin is an effective method of inducing abortion in early pregnancy, the optimum dose of the antigestogen is...

Potential role for medroxyprogesterone acetate as an adjuct to goserelin (Zoladex) in the medical management of uterine fibroids (1992)

West, Christine P., Lumsden, Mary Ann, Hillier, Heideh, Sweeting, Vicky, Baird, David T.

Twenty women with symptomatic uterine fibroids were treated with the luteinizing hormone-releasing hormone (LHRH) agonist goserelin (Zoladex) combined with medroxy-progesterone acetate (MPA) in an...

Glucose phosphate isomerase activity in mouse and human eggs and pre-embryos (1989)

West, John D., Flockhart, Jean H., Angell, Roslyn R., Hillier, Stephen G., Thatcher, Samuel S., Glasier, Anna F., ...

We have measured the activity of glucose phosphate isomerase (GPI-1) in 12 unfertilized human eggs and five human preembryos relative to the GPI-1 activity in C57BL/OlaWs mouse eggs. The GPI-1...

Sexing whole human pre-embryos by in-situ hybridization with a Y-chromosome specific DNA probe (1988)

West, John D., Gosden, John R., Angell, Roslyn R., West, Katrine M., Glasier, Anna F., Thatcher, Samuel S., ...

We have used DNA-DNA In-situ hybridization with a DNA probe for the human Y-chromosome to distinguish between male and female human pre-embryos. Both biotinylated and tritlated Y-probes worked well...

Effects of preovulatory tamoxifen in regularly cycling women on folliculogenesis, oocyte recovery and luteal function (1988)

Thatcher, Sam S., Angell, Ros E., West, John D., Glasier, Anna F., Kelly, Rodney W., Hillier, Stephen G., ...

Forty women undergoing elective sterilization and oocyte donation were randomized in a trial to study the effects of administration of 30 mg of tamoxifen 12 h before injection of human chorionic...

Regulation of human endometrial function: mechanisms relevant to uterine bleeding

Critchley, Hilary OD, Kelly, Rodney W, Baird, David T, Brenner, Robert M

This review focuses on the complex events that occur in the endometrium after progesterone is withdrawn (or blocked) and menstrual bleeding ensues. A detailed understanding of these local mechanisms...